comment on "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease"

被引：0
|
作者：
Costa, Marco [1 ]
机构：
[1] Corpo Redatorial Revista Portuguesa Cardiol, Lisbon, Portugal
来源：
REVISTA PORTUGUESA DE CARDIOLOGIA | 2017年 / 36卷 / 06期
关键词：
PCSK9;
D O I：
10.1016/j.repc.2017.05.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [1] Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
    Sabatine, Marc S.
    Giugliano, Robert P.
    Keech, Anthony C.
    Honarpour, Narimon
    Wiviott, Stephen D.
    Murphy, Sabina A.
    Kuder, Julia F.
    Wang, Huei
    Liu, Thomas
    Wasserman, Scott M.
    Sever, Peter S.
    Pedersen, Terje R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1713 - 1722
  • [2] Evolocumab in Patients with Cardiovascular Disease
    Koskinas, Konstantinos C.
    Windecker, Stephan
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 786 - 786
  • [3] Evolocumab for Patients with cardiovascular Disease First clinical Outcome Data
    Chakaroun, R.
    DIABETOLOGE, 2017, 13 (04): : 272 - 273
  • [4] Evolocumab and Outcomes in Patients With Peripheral Artery Disease
    Bonaca, Marc P.
    Nault, Patrice
    Giugliano, Robert P.
    Keech, Anthony C.
    Pineda, Armando Lira
    Kanevsky, Estella
    Murphy, Sabina A.
    Jukema, J. Wouter
    Lewis, Basil S.
    Tokgozoglu, Lale
    Somaratne, Ransi
    Server, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc S.
    CIRCULATION, 2017, 136 (24) : E451 - E452
  • [5] Evolocumab Alters Vascular Function in Patients With Cardiovascular Disease
    Kannenkeril, Dennis
    Bosch, Agnes
    Striepe, Kristina
    Berner, Laura
    Pietschner, Robert
    Kolwelter, Julie
    Ott, Christian
    Schiffer, Mario
    Achenbach, Stephan
    Schmieder, Roland E.
    CIRCULATION, 2022, 146
  • [6] Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data
    Erviti, Juan
    Wright, James
    Bassett, Ken
    Ben-Eltriki, Mohamed
    Jauca, Ciprian
    Saiz, Luis Carlos
    Leache, Leire
    Gutierrez-Valencia, Marta
    Perry, Thomas L.
    BMJ OPEN, 2022, 12 (12):
  • [7] CLINICAL AND ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE AND VALUE OF EVOLOCUMAB TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN SWEDEN
    Haines, P.
    Sorio-Vilela, F.
    Sandelin, R.
    Villa, G.
    VALUE IN HEALTH, 2018, 21 : S102 - S102
  • [8] Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    O'Donoghue, Michelle L.
    Giugliano, Robert P.
    Wiviott, Stephen D.
    Atar, Dan
    Keech, Anthony
    Kuder, Julia F.
    Im, KyungAh
    Murphy, Sabina A.
    Flores-Arredondo, Jose H.
    Lopez, J. Antonio G.
    Elliott-Davey, Mary
    Wang, Bei
    Monsalvo, Maria Laura
    Abbasi, Siddique
    Sabatine, Marc S.
    CIRCULATION, 2022, 146 (15) : 1109 - 1119
  • [9] Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    O'Donoghue, Michelle L.
    Giugliano, Robert P.
    Sabatine, Marc S.
    CIRCULATION, 2023, 147 (16) : 1258 - 1259
  • [10] Evolocumab and Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: Analysis From FOURIER
    Gencer, Baris
    Mach, Francois
    Murphy, Sabina A.
    De Ferrari, Gaetano M.
    Huber, Kurt
    Lewis, Basil S.
    Ferreira, Jorge
    Kurtz, Christopher E.
    Wang, Huei
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc S.
    Giugliano, Robert P.
    CIRCULATION, 2019, 140
12345